Impact of plasma exchange on indices of demyelination in chronic inflammatory demyelinating polyradiculoneuropathy

We studied the impact of plasma exchange (PE) on indices of primary demyelination in patients of the Canadian multicenter trial of PE in chronic inflammatory demyelinating polyneuropathy (CIDP). Individual motor nerves (median, ulnar, peroneal, tibial) were studied: distal motor latencies (DMLs), proximal and distal compound muscle action potential (M‐wave) amplitudes, negative peak areas and durations, and motor conduction velocities (CVs). Proximal M‐wave amplitudes in individual motor territories, particularly in the ulnar nerve (from below elbow, above elbow, and axillary stimulating sites) demonstrated significant improvement with PE, but not sham exchange. Proximal ulnar M‐wave areas also had significant improvement with PE. Trends toward improvement of individual nerve motor CVs, M‐wave durations, and DMLs did not achieve statistical significance. Proximal M‐wave amplitudes, particularly in the ulnar motor territory, and proximal M‐wave areas (providing a measure of conduction block) were the most sensitive indices of improvement conferred by PE in CIDP. In individual patients, these indices may help judge the efficacy of therapy. © 2000 John Wiley & Sons, Inc. Muscle Nerve 23: 206–210, 2000.

[1]  C Chalk,et al.  Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study. , 1996, Brain : a journal of neurology.

[2]  C. Bolton,et al.  Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study. , 1996, Brain : a journal of neurology.

[3]  W. Litchy,et al.  A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy , 1994, Annals of neurology.

[4]  D. Zochodne,et al.  Upper limb pain in chronic demyelinating polyneuropathy: electrophysiological correlates , 1994, Acta neurologica Scandinavica.

[5]  T. Feasby Inflammatory-demyelinating polyneuropathies. , 1992, Neurologic clinics.

[6]  H. Busch,et al.  Chronic inflammatory demyelinating polyneuropathy. Conduction failure before and during immunoglobulin or plasma therapy. , 1989, Brain : a journal of neurology.

[7]  J. Mendell,et al.  Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. , 1989, Archives of neurology.

[8]  J. Albers,et al.  Acquired inflammatory demyelinating polyneuropathies: Clinical and electrodiagnostic features , 1989, Muscle & nerve.

[9]  J. Daube,et al.  Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. , 1986, The New England journal of medicine.

[10]  V. Mathiowetz,et al.  Reliability and validity of grip and pinch strength evaluations. , 1984, The Journal of hand surgery.

[11]  W. Brown,et al.  Conduction block and denervation in Guillain-Barré polyneuropathy. , 1984, Brain : a journal of neurology.

[12]  R. Dinapoli,et al.  Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment , 1982, Annals of neurology.

[13]  S. Oh Subacute demyelinating polyneuropathy responding to corticosteroid treatment. , 1978, Archives of neurology.

[14]  J. Mcleod,et al.  Chronic relapsing polyneuritis , 1976, Journal of the Neurological Sciences.

[15]  R. Hewer,et al.  Recurrent and chronic relapsing Guillain-Barré polyneuritis. , 1969, Brain : a journal of neurology.

[16]  J. H. Austin OBSERVATIONS ON THE SYNDROME OF HYPERTROPHIC NEURITIS (THE HYPERTROPHIC INTERSTITIAL RADICULO‐NEUROPATHIES) , 1956, Medicine.

[17]  Z. Argov,et al.  Chronic inflammatory demyelinating polyradiculoneuropathy: features and prognostic factors with corticosteroid therapy. , 1988, European neurology.

[18]  W. Engel,et al.  Chronic relapsing (Dysimmune) polyneuropathy: Pathogenesis and treatment , 1981, Annals of neurology.